Hologic ThinPrep 5000, Operator'S Manual, Page: 20 / 346

ThinPrep™ 5000 System Instructions for Use English AW-22289-001 Rev. 003 11-2021 14/36
Table 10 below shows the summary for all sites of the descriptive diagnosis for all Bethesda System
categories.
Table 10: Summary of Descriptive Diagnosis
Descriptive Diagnosis
ThinPrep Conventional
Number of Patients:
6747
N % N %
Benign Cellular Changes: 1592 23.6 1591 23.6
Infection:
Trichomonas Vaginalis 136 2.0 185 2.7
Candida spp. 406 6.0 259 3.8
Coccobacilli 690 10.2 608 9.0
Actinomyces spp. 2 0.0 3 0.0
Herpes 3 0.0 8 0.1
Other 155 2.3 285 4.2
Reactive Cellular Changes
Associated with:
Inflammation 353 5.2 385 5.7
Atrophic Vaginitis 32 0.5 48 0.7
Radiation 2 0.0 1 0.0
Other 25 0.4 37 0.5
Epithelial Cell Abnormalities: 1159 17.2 1077 16.0
Squamous Cell:
ASCUS 501 7.4 521 7.7
favor reactive 128 1.9 131 1.9
favor neoplastic 161 2.4 140 2.1
undetermined 213 3.2 250 3.7
LSIL 469 7.0 367 5.4
HSIL 167 2.5 167 2.5
Carcinoma 1 0.0 3 0.0
Glandular Cell:
Benign Endometrial cells
in Postmenopausal
Women
7 0.1 10 0.1
Atypical Glandular Cells
(AGUS)
21 0.3 9 0.1
favor reactive 9 0.1 4 0.1
favor neoplastic 0 0.0 3 0.0
undetermined 12 0.2 2 0.0
Endocervical
Adenocarcinoma
0 0.0 1 0.0
Note: Some patients had more than one diagnostic subcategory.